708 related articles for article (PubMed ID: 33775672)
21. High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies.
Mairesse A; Favresse J; Eucher C; Elsen M; Tré-Hardy M; Haventith C; Gruson D; Dogné JM; Douxfils J; Göbbels P
Clin Biochem; 2020 Dec; 86():23-27. PubMed ID: 32858061
[TBL] [Abstract][Full Text] [Related]
22. Validation of a multiplex flow immunoassay for detection of IgG antibodies against SARS-CoV-2 in dried blood spots.
Turgeon CT; Sanders KA; Rinaldo P; Granger D; Hilgart H; Matern D; Theel ES
PLoS One; 2021; 16(5):e0252621. PubMed ID: 34048503
[TBL] [Abstract][Full Text] [Related]
23. Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2.
Ye X; Angelo LS; Nicholson EG; Iwuchukwu OP; Cabral de Rezende W; Rajan A; Aideyan LO; McBride TJ; Bond N; Santarcangelo P; Rayford YJ; Ferlic-Stark L; Fragoso S; Momin Z; Liu H; Truong K; Lopez B; Conner ME; Rice AP; Kimata JT; Avadhanula V; Piedra PA
Front Immunol; 2021; 12():693462. PubMed ID: 34691016
[TBL] [Abstract][Full Text] [Related]
24. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
[TBL] [Abstract][Full Text] [Related]
25. Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts.
Bortz RH; Florez C; Laudermilch E; Wirchnianski AS; Lasso G; Malonis RJ; Georgiev GI; Vergnolle O; Herrera NG; Morano NC; Campbell ST; Orner EP; Mengotto A; Dieterle ME; Fels JM; Haslwanter D; Jangra RK; Celikgil A; Kimmel D; Lee JH; Mariano MC; Nakouzi A; Quiroz J; Rivera J; Szymczak WA; Tong K; Barnhill J; Forsell MNE; Ahlm C; Stein DT; Pirofski LA; Goldstein DY; Garforth SJ; Almo SC; Daily JP; Prystowsky MB; Faix JD; Fox AS; Weiss LM; Lai JR; Chandran K
mSphere; 2021 Apr; 6(2):. PubMed ID: 33883259
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of 18 commercial serological assays for the detection of antibodies against SARS-CoV-2 in paired serum samples.
Hanssen DAT; Slaats M; Mulder M; Savelkoul PHM; van Loo IHM
Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1695-1703. PubMed ID: 33733395
[TBL] [Abstract][Full Text] [Related]
27. Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19
Yuen RR; Steiner D; Pihl RMF; Chavez E; Olson A; Smith EL; Baird LA; Korkmaz F; Urick P; Sagar M; Berrigan JL; Gummuluru S; Corley RB; Quillen K; Belkina AC; Mostoslavsky G; Rifkin IR; Kataria Y; Cappione AJ; Gao W; Lin NH; Bhadelia N; Snyder-Cappione JE
Front Immunol; 2021; 12():614676. PubMed ID: 33897682
[TBL] [Abstract][Full Text] [Related]
28. Performance of anti-SARS-CoV-2 antibody testing in asymptomatic or mild COVID-19 patients: A retrospective study in outbreak on a cruise ship.
Kaku N; Nishimura F; Shigeishi Y; Tachiki R; Sakai H; Sasaki D; Ota K; Sakamoto K; Kosai K; Hasegawa H; Izumikawa K; Ariyoshi K; Mukae H; Yasuda J; Morita K; Kohno S; Yanagihara K
PLoS One; 2021; 16(9):e0257452. PubMed ID: 34582459
[TBL] [Abstract][Full Text] [Related]
29. Validation and performance comparison of three SARS-CoV-2 antibody assays.
Paiva KJ; Grisson RD; Chan PA; Huard RC; Caliendo AM; Lonks JR; King E; Tang EW; Pytel-Parenteau DL; Nam GH; Yakirevich E; Lu S
J Med Virol; 2021 Feb; 93(2):916-923. PubMed ID: 32710669
[TBL] [Abstract][Full Text] [Related]
30. Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples.
Mazzini L; Martinuzzi D; Hyseni I; Benincasa L; Molesti E; Casa E; Lapini G; Piu P; Trombetta CM; Marchi S; Razzano I; Manenti A; Montomoli E
J Immunol Methods; 2021 Feb; 489():112937. PubMed ID: 33253698
[TBL] [Abstract][Full Text] [Related]
31. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.
Isho B; Abe KT; Zuo M; Jamal AJ; Rathod B; Wang JH; Li Z; Chao G; Rojas OL; Bang YM; Pu A; Christie-Holmes N; Gervais C; Ceccarelli D; Samavarchi-Tehrani P; Guvenc F; Budylowski P; Li A; Paterson A; Yue FY; Marin LM; Caldwell L; Wrana JL; Colwill K; Sicheri F; Mubareka S; Gray-Owen SD; Drews SJ; Siqueira WL; Barrios-Rodiles M; Ostrowski M; Rini JM; Durocher Y; McGeer AJ; Gommerman JL; Gingras AC
Sci Immunol; 2020 Oct; 5(52):. PubMed ID: 33033173
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19.
Glück V; Grobecker S; Tydykov L; Salzberger B; Glück T; Weidlich T; Bertok M; Gottwald C; Wenzel JJ; Gessner A; Schmidt B; Peterhoff D
Infection; 2021 Aug; 49(4):739-746. PubMed ID: 33689159
[TBL] [Abstract][Full Text] [Related]
33. Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva.
Faustini SE; Jossi SE; Perez-Toledo M; Shields AM; Allen JD; Watanabe Y; Newby ML; Cook A; Willcox CR; Salim M; Goodall M; Heaney JL; Marcial-Juarez E; Morley GL; Torlinska B; Wraith DC; Veenith TV; Harding S; Jolles S; Ponsford MJ; Plant T; Huissoon A; O'Shea MK; Willcox BE; Drayson MT; Crispin M; Cunningham AF; Richter AG
Immunology; 2021 Sep; 164(1):135-147. PubMed ID: 33932228
[TBL] [Abstract][Full Text] [Related]
34. False-positive results of SARS-CoV-2 IgM/IgG antibody tests in sera stored before the 2020 pandemic in Italy.
Latiano A; Tavano F; Panza A; Palmieri O; Niro GA; Andriulli N; Latiano T; Corritore G; Gioffreda D; Gentile A; Fontana R; Guerra M; Biscaglia G; Bossa F; Carella M; Miscio G; di Mauro L
Int J Infect Dis; 2021 Mar; 104():159-163. PubMed ID: 33383223
[TBL] [Abstract][Full Text] [Related]
35. Multicenter evaluation of four immunoassays for the performance of early diagnosis of COVID-19 and assessment of antibody responses of patients with pneumonia in Taiwan.
Lin YC; Lee YL; Cheng CY; Tseng WP; Wu JL; Lin CH; Chung MY; Kang CM; Lee YF; Chen CP; Huang CH; Liu CE; Cheng SH; Chen SC; Chen SY; Hsueh PR
J Microbiol Immunol Infect; 2021 Oct; 54(5):816-829. PubMed ID: 33676864
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect.
Maine GN; Lao KM; Krishnan SM; Afolayan-Oloye O; Fatemi S; Kumar S; VanHorn L; Hurand A; Sykes E; Sun Q
J Clin Virol; 2020 Dec; 133():104663. PubMed ID: 33161369
[TBL] [Abstract][Full Text] [Related]
37. Detection of SARS-CoV-2 IgG antibodies in dried blood spots.
Turgeon CT; Sanders KA; Granger D; Nett SL; Hilgart H; Matern D; Theel ES
Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115425. PubMed ID: 34116343
[TBL] [Abstract][Full Text] [Related]
38. Validation of COVID-19 serologic tests and large scale screening of asymptomatic healthcare workers.
Mullins KE; Merrill V; Ward M; King B; Rock P; Caswell M; Ahlman M; Harris AD; Christenson R
Clin Biochem; 2021 Apr; 90():23-27. PubMed ID: 33472036
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma.
Bundschuh C; Egger M; Wiesinger K; Gabriel C; Clodi M; Mueller T; Dieplinger B
Clin Chim Acta; 2020 Oct; 509():79-82. PubMed ID: 32526218
[TBL] [Abstract][Full Text] [Related]
40. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.
Kowitdamrong E; Puthanakit T; Jantarabenjakul W; Prompetchara E; Suchartlikitwong P; Putcharoen O; Hirankarn N
PLoS One; 2020; 15(10):e0240502. PubMed ID: 33035234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]